Cibc Asset Management Inc Akoya Biosciences, Inc. Transaction History

Cibc Asset Management Inc

  • $28.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$3.13 - $5.13 $230,796 - $378,270
73,737 Added 175.95%
115,644 $564,000
Q2 2023

Aug 14, 2023
SELL
$5.28 - $8.35 $951,852 - $1.51 Million
-180,275 Reduced 81.14%
41,907 $309,000
Q1 2023

May 12, 2023
SELL
$7.6 - $12.68 $238,184 - $397,391
-31,340 Reduced 12.36%
222,182 $1.82 Million
Q3 2022

Nov 03, 2022
BUY
$10.63 - $15.76 $2.69 Million - $4 Million
253,522 New
253,522 $2.98 Million

Others Institutions Holding AKYA

# of Institutions
58
Shares Held
12M
Call Options Held
24.1K
Put Options Held
0
View Full List

About Akoya Biosciences, Inc.

AKYA Quotes by TradingView
  • Ticker AKYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,892,300
  • Market Cap $107M
  • Description
  • Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...
More about AKYA
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email